Despite a small number of data associating ERβ with pro-growth and pro-survival when present alone in ERα-negative estrogen related cancer tissues and cells, a large number of data both in vitro and in vivo support that ERβ acts as an anti-proliferative and pro-apoptotic factor, especially when co-expressed with ERα44,45. This evidence concerns the gene ESR2 and cancer.